Summary Statistics from the Swedish National Cancer Registry based on all 110,658 cases of invasive breast cancer during the 31-year period were analysed. Age-specific incidence rates increased over successive calendar periods. The average annual increase in the age-standardised incidence rate was 1.3%, with the greatest percentage changes among the youngest age groups. During the latter half of the study period, the rates of increase tended to diminish in the youngest age groups and even reversed significantly among women from 75 years of age. In analyses using age-period-cohort models, the best fit of the cancer incidence data was found for the full model which simultaneously considered the effects of age, period and cohort. Cohort effects were found to be more important than period effects, in terms of model fit. These effects emerged as a seemingly consistent, and in a logarithmic scale, fairly linear increase in the relative risk of breast cancer incidence with a 3-fold elevation in women born in the 1950's relative to those born in the 1880's It is concluded that the rising breast cancer incidence in Sweden is explained chiefly by birth cohort effects, which indicate persistent secular changes in largely unknown risk factors associated with life style. We could not in the present data see any clear evidence for an adverse effect of contraceptive or replacement sex steroids on breast cancer incidence.
Breast cancer is the most frequent female cancer in Western Europe and the US, both in terms of incidence and mortality (Parkin & Nectoux, 1991; Stjernsward & Koroltchouk, 1988; Kohlmeier et al., 1990) . Its occurrence has been increasing substantially in various countries worldwide (Parkin & Nectoux, 1991; Miller & Bulbrook, 1986 ), resulting in lifetime cumulative incidence rates ranging from 3% in Japan to 9% in the USA (Muir et al., 1987) .
In the US and the Nordic countries, age-adjusted breast cancer incidence has increased by 40-70% during the last 3-4 decades (Muir et al., 1987; Devesa et al., 1987; Glass & Hoover, 1990; Holford et al., 1991; Hakulinen et al., 1986; Ewertz & Carstensen, 1988) . This has been observed in both pre-and postmenopausal age groups (Parkin & Nectoux, 1991) . However, in some populations the increase has been concentrated mostly among younger women (Devesa et al., 1987; Ewertz & Carstensen, 1988; Caygill & Hill, 1991; Ranstam et al., 1990; White et al., 1987) , while in others (such as the USA) it has been seen largely in the oldest groups (Glass & Hoover, 1990 ). The incidence trends are in several countries most importantly explained by increases in successive birth cohorts Hakulinen et al., 1986; Ewertz & Carstensen, 1988) . Therefore, factors that change from one generation to another should be considered as possible explanations (Kelsey, 1979; Moore et al., 1983) .
Of special interest is the fairly recent introduction of combined oral contraceptives (COC's) and hormone replacement therapy (HRT) in the postmenopausal period. Such exogenous hormones have been associated with an increased risk of breast cancer (UK National Case Control Study Group, 1989; Steinberg et al., 1991) . Studies of Swedish women (Meirik et al., 1986; Bergkvist et al., 1989) reported a 70% increased risk of pre-and postmenopausal breast cancers after more than 12 and 9 years of exposure to COC's and HRT, respectively. As the intake has become widespread in Sweden since the 1970's -with some 80% of young women having ever used COC's (Meirik, 1986) and 20% of perimenopausal women HRT (Lindgren, 1993) -it was considered important to look for evidence of an effect on the incidence. Our aim was to analyse the national breast cancer statistics in Sweden, 1958 Sweden, -1988 (Mattsson & Wallgren, 1984) . The reporting is now considered to be close to 100% of all diagnosed cases (The Cancer Registry, 1991 (The Cancer Registry, 1991) ). Both linear and non-linear models in time were estimated. Linear models, which allowed differences between subperiods -of interest in relation to the introduction of COC's and HRT on the (1959-1963, . . . 1984-1988) , which implied 18 overlapping birth cohorts (1875-84, 1880-89, ... 1960-69) . The ageperiod-cohort models were estimated using the Breslow method (Breslow, 1984) which adjusts for overdispersion. The age-period-cohort modelling is further discussed in a statistical Appendix.
Results
Age-specific and age-adjusted incidence rates, by year of diagnosis 1958-1988 Trends in incidence rates over the 31 year long study period in nine age groups are illustrated in Figure 1 . In general, the rates increase steadily in all age groups, especially in the four youngest age-groups. However, the rate of increase appears to slow down slightly in these and the oldest age groups, as well as in the age-adjusted curve, during the latter part of the observation period.
Incidence trends were analysed, first by assuming the same rate of change during the whole period (Table II ). The age-standardised incidence increased annually by 1.3%. A significant average annual increase was found in all agegroups, ranging from 0.9 to 3.0%; the most marked rise was seen in the two youngest age-groups. To test for possible non-linear trends, also models including a quadratic trend term were also estimated (Table II) . For the three oldest age-groups, the quadratic trend term was negative and strongly significant, indicating that the rate of increase slowed down in recent years. For all age-groups below 60, except the 40-44 group, this term was negative but statistically insignificant. In the three age-groups 60-74 years, the parameter of the quadratic term was positive.
To further elucidate the incidence trends over time -and to reflect an early period when COC's and HRT were prescribed to only few women and a later one with a rapid introduction of these respective hormonal drugs -separate estimates were calculated for the two periods 1958-1973 and 1974-1988 (Table III ). The age-standardised incidence increased annually on the average by 1.5% and 0.9% in the two periods respectively, the growth rate being significantly slower in the latter period. Among the individual age-groups the results were consistent with those obtained with the quadratic trend model. Thus, the growth rate of the incidence dropped considerably in the three oldest age-groups, showing an actual decrease in the rates. The reduction in growth rates between periods was also large in the two youngest agegroups, although not statistically significant. If other cut-off years than 1974 were used for the definition of the subperiods, e.g. 1977, similar results were obtained.
Age-period-cohort analyses Age-period-cohort modelling revealed some overdispersion in the full model, the deviance being 82.22 on 44 degrees of freedom (Table IV) . On the basis of the standard Poisson model, the full model was superior to both the age-period and age-cohort models. The fit of the age-cohort model (adjusted R2A-value of 0.883), was better than with the ageperiod model (R2A = 0.849), while the fit of the full model was 0.907. Accounting for the extra-Poisson variation confirmed that the age-cohort model was inferior to the full model (Table IV) . The greater importance of the cohort than the period effects was also seen when the submodels were tested against the full model. Addition of cohort to an ageperiod model gave a significant P-value of t0.1%, while addition of period to an age-cohort model gave a P-value t1%.
Application of the full model for the presentation of age, period and cohort effects requires a further assumption in order to obtain unique parameter estimates (Clayton & Schifflers, 1987) . As cohort effects were more important, i.e. the age plus cohort model produced a better fit than the age plus period model (Table IV) , we imposed the restriction that the linear period effect was assumed to be zero (Clayton & Schifflers, 1987) . Cohort effects were computed according to this approach. Figure 2 shows the relative incidence (log scale) with the oldest cohort of women born in 1875-1884 as reference. aLog-linear models. Test of equal growth rates in the two subperiods. bp = 0.001. cp <0.0001. dp = 0.041.
Generally, the rate of increase appeared to diminish with time, 0.9% in the latter half of the period as compared with 1.5% in the earlier half of the period. Increased diagnostic activities, notably mammographic examinations, may enhance incidence rates (White et al., 1990) . In Sweden, mammography on clinical grounds became widespread from the mid 1970's (Bjurstam et al., 1978 (Muir et al., 1987; Devesa et al., 1987; Glass & Hoover, 1990; Holford et al., 1991; Hakulinen et al., 1986; Ewertz & Carstensen, 1988) , also for less recent time periods than the present one. For instance, in the USA, overall increases in age-adjusted incidence rates have been fairly stable and in the order of 31% (Devesa et al., 1987) to 45% (Glass & Hoover, 1990) from the 1950-60's up through the early 1980's, whereafter an accelerated increase took place. In Denmark the increase was around 60% during a 40-year period, through 1982 (Ewertz & Carstensen, 1988) and in other Nordic countries about 40% during a 25-year period (Hakulinen et al., 1986 ). The age-specific incidence patterns seemed to differ, however, between the US and the Nordic countries. Whereas statistics from Portland, Oregon, showed the greatest rise in the incidence among those 60 + years old and no change among those 20-44 years old (Glass & Hoover, 1990) , data from Nordic countries, including the present data, indicated the greatest proportional increase in age-groups below 50 (Ewertz & Carstensen, 1988) . Indeed, we found a significant decrease in recent years among women 75 years and older (Table III) . In most previous studies, marked cohort effects were noted Hakulinen et al., 1986; Ewertz & Carstensen, 1988) , which were judged to be the most important explanation in studies analysing simultaneously the effects of age, period and cohort (Holford et al., 1991; Ewertz & Carstensen, 1988) .
Assuming that these data reflect real changes in the onset rates of breast cancer, what etiological hypotheses are plausible? If the increases are mainly associated with birth cohort, then data in Figure 2 indicate the need to focus on exposures that have changed in a constant way from one generation to the next. Secular trends with decreasing age at menarche, increasing adult height and more frequent intake of alcoholestablished or tentative risk factors of breast cancer -in women born in the 1940-50's as compared with those in the early part of the century can explain only little of the development (Harris et al., 1992) .
Epidemiological studies have implicated long-term exposure to both combined oral contraceptives and hormone replacement therapy as risk factors for pre-and postmenopausal breast cancers, respectively (UK National Case Control Study Group, 1989; Steinberg et al., 1991; Meirik et al., 1986; Bergkvist et al., 1989) . Both these exposures have become wide-spread in Western societies in the two last decades and might therefore contribute to an increased rate of breast cancer (Harris et al., 1992) . Thus, in Sweden, combined oral contraceptive pills were introduced in 1964 and became extensively used in the 1970's, especially by young women leading to ever usage rates in 1980's of 70-80%, and intake for more than 4 years in some 40% of all exposed women (Meirik et al., 1986) . Statistics on the number of defined sold daily doses relative to the population (Figure 3a , National Corporation of Pharmacies, 1991) demonstrate greatly increasing use of COC's during the mid-and late 1970's, thereafter fluctuating and decreasing slightly. If the risk of breast cancer is increased 1.5-2-fold after longterm intake of combined oral contraceptives (Meirik et al., 1986) 1973 1975 1977 1979 1981 1983 1985 1987 1989 1991 1972 1974 1976 1978 1980 1982 1984 19861988 1990 1972 1974 1976 1978 1980 1982 1984 1986 1988 1990 1973 1975 1977 1979 1981 1983 1985 1987 1989 Year Figure 3 (Bergkvist et al., 1989 (Figure 3b ), with present ever usage rates of about 20% (Lindgren, 1993) . From a recent survey (unpublished data) in a cohort of oestrogen treated women in Sweden (Persson et al., 1983) , it was estimated that more than 50% of the exposed women had an intake exceeding 6 years. However, our data give no clear evidence of an effect of exogenous hormone exposure, since we found seemingly linear trends in relative risk over birth cohorts without further increase in women born in the interval 1925-1940. Moreover, the slowing of the rate of incidence increase in recent time periods, further contradict a major impact of exogenous hormone exposure in Swedish women.
The present findings among the Swedish women may be due partly to changes in other factors, e.g. a somewhat increased age at menopause (Bengtsson et al., 1981) and a substantially decreased age at menarche (Ljung et al., 1974) in the recent birth cohorts as compared with later ones.
However, nulliparity and age at first birth are less likely to be of importance, since the proportion of 40 years old nulliparous women has not changed substantially. Fertility rates have rather fluctuated substantially, with the lowest proportion of nulliparous women at the attained age of 20 years for women born in 1945 -1949 (Population Statistics, 1990 (Ewertz et al., 1990) , including Sweden (Adami et al., 1990) , to explain more than a minor part of the 3-fold difference in breast cancer risk among women born some 70 years apart.
Hypothetically, endocrine events in the adolescence period related to improved nutrition and growth acceleration at an early age (Harris et al., 1992; De Ward & Trichopoulos, 1988) , as well as intake of larger quantities of alcohol (Longnecker et al., 1988 ) -in women of younger birth cohorts, may also be important. It has also been suggested that intrauterine exposures may influence breast cancer risk (Ekbom et al., 1992) . Evidently, temporal trends in such exposures would produce birth cohort effects in incidence.
In summary, we find a constant increase of breast cancer risk with birth cohort and reduced rate of increase in recent time periods. This points to the importance of unidentified factors that have been successively introducted to -or withdrawn -from the Swedish population. Our data, however, give no clear support -at this time of observation -to the assumption that oral contraceptive pills or hormone replacement increase breast cancer incidence.
Statistical appendix:
To obtain the effects of age, cohort, and period on breast cancer incidence, models were fitted on the assumption that the number of cases constituted a variable with a Poisson distribution. The effects of age, cohort and period were assumed to be multiplicative, and the parameters of the models were estimated by means of the maximum likelihood method using the program package GLIM (Clayton & Schiffiers, 1987) .
In all analyses, the number of observed cases in each of the age-period observational cells was generally greater than 100. Basically, it was assumed that the number of cases observed had a Poisson distribution, but here the distribution can be approximated by the normal distribution, which was confirmed in the actual estimation. The large number of observed cases in situation such as the present one often causes overdispersion (Breslow, 1984) . This means that the unexplained variance is larger than that expected under a Poisson assumption, without any apparent mis-specification of the model. To overcome these difficulties, we used the approach suggested by Breslow (Breslow, 1984) , to adjust for the overdispersion. The Breslow method based on weighted least squares was employed.
The overdispersion made it unsuitable to employ tests based on the chi-square distribution. In the testing of different models, F tests were performed on the basis of the extra-Poisson models, as well as on the deviances of the standard Poisson models. The results were similar (Table IV) . The method allowing for extra-Poisson variability gave parameter estimates that were very close to the standard maximum likelihood estimates of the Poisson model without adjustment for overdispersion.
As a measure of the fit of different models compared with the age-model we have used statistics of the following type G2A+p/dfA+P R A= IG2AIdfA where G2 denotes the deviance and df the number of degrees of freedom. This measure shows how much of the variability that is explained by other factors than age. Inclusion of the degrees of freedom terms makes it possible to compare two models with a different number of degrees of freedom.
In the analyses of age-period-cohort models, a fundamental problem is the linear dependence between the linear age, period and cohort effects. The non-linear effects, on the other hand, are uniquely defined, but a meaningful interpretation requires that the linear effects be included. As the full ageperiod-cohort model was a significant improvement on the submodels, the full model should be used for the computation of effects of different factors. However, this requires further restrictions in order to obtain unique linear effects. Such restrictions cannot be avoided, but they all have drawbacks. Our choice, following Holford (1991) was based on the fact that cohort effects were stronger than the period effects. We therefore assumed that the linear period effect had a zero slope. With this assumption, it was possible to obtain estimates of all parameters in the model. The results presented actually implied a slight modification of this principle, as the restriction used was that the first and last period effects were equal to zero. This produced results that were very close to those obtained with the zero period slope assumption, and the computations were easier. The procedure actually used by us in fact the normalisation rule suggested by Clayton and Schiffiers (1987) . This work was supported by grants from the Swedish Cancer Society.
